Florida Surgeon General and Secretary of Health John Armstrong, M.D., presented the state’s Cancer Center of Excellence Award to Sylvester Comprehensive Cancer Center on April 17, making it the only South Florida cancer center to receive the distinguished award.
Pascal J. Goldschmidt, M.D., Senior Vice President for Medical Affairs and Dean of the Miller School of Medicine and CEO of UHealth, opened the program by welcoming Armstrong and other distinguished visitors. He cited Sylvester’s treatment of more than 5,000 new cancer patients each year and credited the visionary leadership of Stephen D. Nimer, M.D., Sylvester’s Director, with attracting the top clinicians and researchers necessary to build a world-class cancer center.
A new treatment strategy for stroke patients using a retrievable stent to open large arteries in conjunction with “clot-busting” medication can dramatically reduce long-term disability, according to a ground-breaking study published online April 17 in the New England Journal of Medicine.
Dan Brooks, an Indian River County firefighter and father of four, is not one to complain easily. Six years ago, he began experiencing pain on the side of his face. At first, it came and went, but over time the searing pain grew more intense and occurred more frequently.
In a groundbreaking laboratory study, a research team at Sylvester Comprehensive Cancer Center has found that a non-toxic oral agent that is also consumed as an over-the-counter dietary supplement in Europe and Asia for improving liver health, is highly effective in both preventing and treating prostate cancer. Additionally the agent was able to halt the metastatic spread of the disease.
The morning after being named the next President of the University of Miami, Julio Frenk, M.D., M.P.H., Ph.D., currently Dean of Harvard University’s T.H. Chan School of Public Health, met with clinical chairs and other leadership at the Miller School of Medicine.
A gene mutation causing a form of hereditary deafness has been identified by an international team of researchers led by Xuezhong Liu, M.D., Ph.D., Leonard M. Miller Professor and Vice Chair for Research in Otolaryngology and Director of the Center for Hereditary Deafness at the University of Miami Miller School of Medicine.